Health status changes in COPD patients after real-life switch from tiotropium or salmeterol/fluticasone to indacaterol/glycopyrronium using the EQ-5D-3L instrument: results from the POWER study

Conclusion: In clinical practice, IND/GLY direct switch provided clinically significant improvements in lung function and translated into improved health status as per the EQ-5D-3L tool regardless of former TIO or SFC in patients with moderate-to-severe COPD.

Source: European Respiratory Journal - November 19, 2018 Category: Respiratory Medicine Authors: Anees, S., Mcivor, A., Chapman, K. R., Mayers, I., Rochdi, D., Prefontaine, D., Kaplan, A. Tags: Airway pharmacology and treatment Source Type: research